A carregar...
Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis
BACKGROUND: Despite the widespread use of erythropoietin-stimulating agents (ESAs) to treat anemia in patients undergoing hemodialysis, the relative mortality risks associated with use of different types of ESAs are unknown. METHODS: To compare the mortality risk associated with use of short-acting...
Na minha lista:
| Publicado no: | J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Nephrology
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6551773/ https://ncbi.nlm.nih.gov/pubmed/31015255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018101007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|